HIGHLIGHTS
- who: Zhu Zhang and collaborators from the Teaching and Research Division, School of Chinese Medicine, Hong Kong Baptist University, Department of Biology, Hong Kong Baptist University, Hong Kong, China have published the research work: Therapeutic Intervention in Cancer by Isoliquiritigenin from Licorice: A Natural Antioxidant and Redox Regulator, in the Journal: Antioxidants 2022, 11, 1349. of /2022/
- what: In the past, research on licorice was focused on glycyrrhizin, but recently, other bioactive constituents have also been vigorously studied for different therapeutic purposes, including their potential neuroprotective and anticancer effects. The authors have determined the promotional . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.